Article info

Download PDFPDF

Original research
Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Authors

  1. Correspondence to Dr Anant Madabhushi; axm788{at}case.edu
View Full Text

Citation

Jazieh K, Khorrami M, Saad A, et al
Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Publication history

  • Accepted January 14, 2022
  • First published March 7, 2022.
Online issue publication 
January 25, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.